
FBRX P/E Ratio
P/E Ratio as of Sep 16, 2026: -15.01
Average-15.00
Median-15.01
Minimum-15.01
Maximum-14.99
-15.01
0.03 (0.20%)past month
The P/E ratio for FBRX is -15.01 as of Sep 16, 2026. This represents a increase of 138.63% compared to its 12-month average P/E ratio of -6.29. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Forte Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Forte Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Forte Biosciences Inc to industry peers.
Forte Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Forte Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Forte Biosciences Inc to industry peers.
FBRX P/E Ratio Insights
See Forte Biosciences Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in FBRX
Order type
Buy in
Order amount
Est. shares
0 shares
FBRX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Sep 1, 2026 | — | -15.01 |
| Aug 3, 2026 | $76.61 | -15.00 |
| Jul 1, 2026 | $21.32 | -4.17 |
| Jun 1, 2026 | $19.24 | -3.77 |
| May 1, 2026 | $28.19 | -5.38 |
| Apr 1, 2026 | $24.86 | -4.74 |
| Mar 2, 2026 | $30.65 | -6.90 |
| Feb 2, 2026 | $34.49 | -7.76 |
| Jan 2, 2026 | $23.61 | -5.31 |
FBRX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -15.01 | +144.46% |
| 2025 | -6.14 | +424.79% |
| 2024 | -1.17 | +77.27% |
| 2023 | -0.66 | -48.03% |
| 2022 | -1.27 | -7.30% |
| 2021 | -1.37 | — |
FAQs About Forte Biosciences Inc (FBRX) P/E ratio
The latest P/E ratio of FBRX is -15.01, as of Sep 16, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Forte Biosciences Inc’s last 12-month average P/E ratio is -6.29, compared to its current P/E ratio of -15.01. This reflects a increase of 138.63%.
Forte Biosciences Inc’s current P/E ratio of -15.01 is higher than its last 12-month average P/E of -6.29. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Forte Biosciences Inc’s average P/E ratio over the last 3 years is -2.52. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Forte Biosciences Inc’s average P/E ratio over the last 5 years is -1.98. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.